Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Provides Software for Industrial Biotech Consortium, Expands License with Takeda

Premium

Genedata said this week that its Selector software is being used by the Integrated Phenotype-Genotype project — a consortium of companies in the biotechnology industry — to analyze and manage data from production strains and processes in industrial biotechnology.

The IPG project aims to develop a platform for biotech strain and process development that integrates high-throughput phenotyping and genotyping and can identify complex genetic effects that influence biotechnologically relevant production phenotypes.

Genedata explained that the project platform is based on its Selector software and enables large-scale, cross-strain comparisons by systematically identifying mutation hotspots that pinpoint novel targets for de-bottlenecking as well as metabolic engineering of production strains. The platform uses parallelized, multiplexed phenotype assays to process, store, and mine large volumes of data.

In a statement, Stephan Hans, a senior scientist at consortium member Evonik Industries, noted that "correlating the productivity of our proprietary microbial production strains with their genotypes ... is extremely challenging, in particular matching the synergistic combinations of mutations against a high background of random mutations."

He explained that Selector meets this challenge by identifying "genomic changes and [isolating] non-beneficial or even detrimental mutations," which allows development groups to "identify hidden metabolic bottlenecks in our biotech production."

Separately, Genedata announced that Takeda Pharmaceutical has expanded its license for Genedata Expressionist.

Currently, Takeda uses the tool for managing and analyzing mass spectrometry data for both metabolomics and proteomics research and development.

With the expanded license, Takeda will have access to the latest release of Expressionist, which includes improvements in multi-vendor MS data integration, support for untargeted proteomics and metabolomics, and targeted multiple reaction monitoring.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.